The stock has gained 31 percent over the past year, giving the company a market value of $59 million. The company plans on marketing the implants in the second half of 2011, according to the report.
Read the Bloomberg Businessweek report on Mazor Robotics.
Read other coverage on Mazor:
– Mazor’s SpineAssist Clinical Study Shows 98% Accuracy in Implant Placement
– Mazor Receives FDA Approval for SpineAssist and C-InSight For Spine Surgery
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
